ArticleHealth science reports2025
Unveiling the Disparities in the Field of Precision Medicine: A Perspective.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Precision medicine in low-income settings and small island developing states.Nature reviews. Endocrinology · 2026Review
- Precision for all children: embedding equity into precision medicine for children.BMJ paediatrics open · 2026Article
- Prioritising Data Quality Governance for AI in Prostate Cancer: A Methodological Proof-of-Concept Study Using Neural Networks for Risk Stratification.Diagnostics (Basel, Switzerland) · 2026Article
- Precision Oncology: Current Landscape, Emerging Trends, Challenges, and Future Perspectives.Cells · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Precision medicine prescribes medication based on genetic data, social history, and environment, offering more effective care. This article presumes that many disparities shatter this promise for numerous groups. The article discusses the challenges of personalized medicine in relation to disparities, proposes solutions, and introduces strategies to address these issues. Methods: A comprehensive literature review was done to understand precision medicine, its implementation challenges, and possible answers. Academic databases, including Google Scholar, PubMed, and Scopus, were searched for relevant studies and peer-reviewed articles. Peer-reviewed precision medicine articles in oncology, internal medicine, public health, and obstetrics and gynecology were included to provide a broad and interdisciplinary perspective. Results: The concept of precision medicine needs to be implemented throughout many levels of society and healthcare systems around the world. Access to genomic data is limited in high-income countries, and socioeconomic disparities hinder healthcare equality, particularly for low-income individuals or those without insurance. The digital divide, lack of education, ethical concerns, and regulatory frameworks contribute to disparities in personalized medicine. We believe that health equity will be achieved by addressing these discrepancies and suggesting some strategies to overcome them. Conclusion: Precision medicine has successfully treated and helped in the early detection of many diseases, like severe asthma, cancer, and type 1 diabetes. Socioeconomic position, education, data, access, and regulatory frameworks prevent minorities and low-income populations from using it. For instance, lack of awareness and other inequalities in access to precision medicine limit T1DM HLA typing and autoantibody surveillance. These discrepancies must be addressed to improve minority and low-income T1DM patients' outcomes. The patient-oriented strategy is cost-effective and includes benefits through education, genetic data diversity promotion, and increased access, but regulatory frameworks are essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.